Ординатура / Офтальмология / Английские материалы / Oxford American Handbook of Ophthalmology_Tsai, Denniston, Murray_2011
.pdf736 |
INDEX |
|
|
|
|
|
Optic nerve hypoplasia, 535 |
exophthalmometry, 37 |
chromosomal locations |
|
|
Optic nerve sheath |
two-ruler test, 37 |
of gene, 605 |
|
|
meningioma, 488 |
Orbital floor fractures |
inheritance patterns, 604 |
|
|
Optic nerve vs. macular |
assessment, 87–8 |
glaucoma, 630–1 |
|
|
disease, 520 |
repair for, 89 |
intrauterine infections, 619 |
|
|
Optic neuritis, assessment |
surgical intervention in, 89 |
metabolic and storage |
|
|
of, 522–3 |
treatment, 89 |
diseases, 640 |
|
|
Optic neuropathy, |
Orbital roof fractures, 88 |
ophthalmia neonatorum, |
|
|
assessment of, 519–20 |
Orbital septum and tarsal |
621–2 |
|
|
Optic radiation, 515 |
plates, 106 |
orbital cellulites, 623 |
|
|
|||
|
|
Optic tract, 515 |
P |
phakomatoses, 644–5 |
|
|
Orbicularis oculi, 104 |
preseptal cellulites, 623–4 |
|
|
|
Orbit |
retinal dysplasia, 634 |
|
|
|
anatomy and physiology, |
Painful red eye, in contact |
retinopathy of |
|
|
470 |
lens wearer, 215 |
prematurity, 632–3 |
|
|
bones of, 470 |
Papilledema, 530–2 |
-like syndromes, 634 |
|
|
cystic lesions |
pseudopapilledema, 532 |
retinochoroidal disorders, |
|
|
cephalocele, 486 |
Papillomas, 114 |
634 |
|
|
dacryops, 485 |
pedunculated form, 156 |
uveitis, 628–9 |
|
|
dermoid cyst, 485 |
sessile form, 156 |
Pediculosis, 108 |
|
|
mucocele, 485–6 |
Paralytic ectropion, 118 |
Pegaptanib, 415, 431 |
|
|
mucormycosis, 474 |
Paranasal sinuses, |
Pelli–Robson chart, 11 |
|
|
orbital cellulitis, 472 |
development of, 624 |
schematic example of, 12 |
|
|
orbital inflammations, |
Parasympathetic nervous |
Pellucid marginal |
|
|
483–4 |
system, 518 |
degeneration, 194 |
|
|
dacryoadenitis, 484 |
Parasympathetic pathway |
Penetrating keratoplasty |
|
|
idiopathic orbital |
light response, 27 |
(PK), 205–6 |
|
|
inflammatory disease, |
near response, 27 |
Penetrating trauma/IOFBs |
|
|
483 |
sympathetic pathway, 27 |
assessment, 95–6 |
|
|
idiopathic sclerosing |
Parasympathomimetics, 294 |
treatment, 97–8 |
|
|
inflammation of the |
Parinaud dorsal midbrain |
Penicillin, 168, 360 |
|
|
orbit, 483 |
syndrome, 546 |
Penicillin G, 357 |
|
|
myositis, 484 |
Parinaud’s oculoglandular |
Peribulbar block, 690–1 |
|
|
Tolosa—Hunt |
syndrome, 152 |
Periodic alternating |
|
|
syndrome, 484 |
Parks–Bielschewsky 3-step |
nystagmus (PAN), 558 |
|
|
Wegener’s |
test, 32 |
Perioperative care |
|
|
granulomatosis, 484 |
Past medical history |
anaphylaxis, treatment |
|
|
orbital tumors |
(PMH), 2 |
of, 693 |
|
|
fibrous histiocytoma, 491 |
Past ophthalmic history |
ocular anesthesia, 690–1, |
|
|
lacrimal gland, 487 |
(POH), 2 |
692 |
|
|
lymphoproliferative, 490 |
Patau syndrome, 638 |
preoperative assessment, |
|
|
metastases, 491 |
clinical features, 639 |
686–7, 688 |
|
|
neural, 487–8 |
Pattern dystrophy, 460 |
Peripheral corneal diseases |
|
|
rhabdomyosarcoma, 491 |
Pattern electroretinogram |
dellen, 199 |
|
|
vascular, 489 |
(PERG), 73 |
marginal keratitis, 198 |
|
|
preseptal cellulites, 472–3 |
Pattern standard deviation |
phlyctenulosis, 198–9 |
|
|
thyroid eye disease (TED), |
(PSD), 54 |
rosacea associated |
|
|
475–7 |
Pause cells, 543–5 |
keratitis, 198 |
|
|
assessment, 478–9 |
Pediatric ophthalmology |
Terrien’s marginal |
|
|
autoimmune thyroid |
blind children, 608–9 |
degeneration, 199 |
|
|
disease, 475 |
cataract, 625 |
Peripheral fields, |
|
|
clinical features, 475–7 |
assessment, 625 |
constriction of, 49 |
|
|
emergencies in, 476 |
management, 627 |
Peripheral retinal |
|
|
management, 481–2 |
child abuse, 610 |
degenerations, 377–8 |
|
|
pathogenesis, 475 |
chromosomal syndromes, |
Cobblestone |
|
|
risk factors, 475 |
638 |
degeneration, 378 |
|
|
vascular lesions, 492 |
clinical presentations, 611 |
lattice degeneration, 377 |
|
|
arteriovenous fistula, 492 |
developmental |
Meridional folds, 378 |
|
|
orbital varices, 492 |
abnormalities, 635–7 |
Pavingstone degeneration, |
|
|
Orbital cellulitis, 472, 623 |
embryology, 600–1 |
378 |
|
|
features of, 624 |
examination, 606, 607 |
peripheral cystoid |
|
|
Orbital examination, 36–7 |
genetic disorders, 604, 605 |
degeneration, 377 |
740 |
INDEX |
|
|
|
|
|
Subacute sclerosing |
systemic medication, 705 |
carbonic anhydrase |
|
|
panencephalitis (SSPE), |
other systemic |
inhibitors, 703 |
|
|
346 |
immunosuppressants, |
combinations with timolol, |
|
|
Subtenon’s block, 690 |
709–10 |
703 |
|
|
Sulfonylurea, 424 |
topical antibiotics, 698 |
miotics, 703 |
|
|
Superior oblique myokymia, |
topical anti-inflammatory |
prostaglandin analogues, |
|
|
559 |
agents, 700–1 |
702 |
|
|
Supranuclear eye movement |
corticosteroids, 700 |
sympathomimetics, 702 |
|
|
disorders, 543–5 |
topical antihistamines, |
Toxic conjunctivitis, 152 |
|
|
horizontal gaze, disorders |
701 |
Toxic keratopathy, 215 |
|
|
of, 544–5 |
topical glaucoma |
Toxic retinopathies, 435–6 |
|
|
vertical gaze palsies, 546 |
medications, 702–3 |
chloroquine, 435 |
|
|
Supranuclear gaze palsies, |
β-blockers, 702 |
chlorpromazine, 437 |
|
|
546 |
carbonic anhydrase |
clofazimine, 438 |
|
|
Suprathreshold tests, 53 |
inhibitors, 703 |
deferoxamine, 437–8 |
|
|
Swedish interactive |
combinations with |
didanosine, 438 |
|
|
threshold algorithm |
timolol, 703 |
hydroxychloroquine, 435 |
|
|
(SITA), 56 |
miotics, 703 |
tamoxifen, 437 |
|
|
Sympathetic nervous |
prostaglandin analogues, |
thioridazine, 437 |
|
|
system, 518 |
702 |
vigabatrin, 436 |
|
|
Sympathetic ophthalmia, 344 |
sympathomimetics, 702 |
Toxocariasis, 364 |
|
|
Sympathomimetics, 292 |
Thioridazine, 437 |
Toxoplasma |
|
|
Syphilis, 357, 358 |
Third nerve, 516 |
retinochoroiditis, 352 |
|
|
Syphilis choroiditis, 353 |
disorders, 547–9 |
Toxoplasmosis, 361–3 |
|
|
|
Threshold testing, 53 |
Trabecular meshwork, 601 |
|
|
T |
Thygeson’s superficial |
Trachoma, 144–5 |
|
|
punctate keratopathy, |
Tractional retinal |
|
|
|
Tachyzoite, 361–3 |
179 |
detachment (TRD), 375 |
|
|
Tacrolimus, 335, 709, 710 |
Thymectomy, 563 |
Transeptal/subtenons, 429 |
|
|
Tamoxifen, 437 |
Thyroid eye disease (TED), |
Transpupillary |
|
|
Tangent screen, 50 |
475–7 |
thermotherapy (TTT), |
|
|
Tear film breakup time |
assessment, 478–9 |
498–9 |
|
|
(BUT), 18 |
autoimmune thyroid |
Transscleral |
|
|
Tear film disturbance, 215 |
disease, 475 |
cyclophotocoagulation, |
|
|
Telecanthus, 124 |
clinical features, 475–7 |
297 |
|
|
Teller acuity cards, 9 |
emergencies in, 476 |
Trauma, C3 |
|
|
Tension headache, 655 |
management, 481–2 |
blunt trauma |
|
|
Terrien’s marginal |
pathogenesis, 475 |
assessment, 92–3 |
|
|
degeneration, 199 |
risk factors, 475 |
treatment, 94 |
|
|
Terson syndrome, 610 |
Thyroid ophthalmopathy. |
chemical injury |
|
|
Tetanus prophylaxis, 83 |
See Thyroid eye disease |
assessment, 84 |
|
|
indications for, 83 |
(TED) |
treatment, 86 |
|
|
Tetracycline, 141, 360 |
Tight lens syndrome, 215 |
corneal foreign bodies and |
|
|
Therapeutics |
TINU, 327–8 |
abrasions, 99 |
|
|
mydriatics and |
Titanium:saphire laser |
hyphema, 100–1 |
|
|
cycloplegics, 697 |
trabeculoplasty (TLT), |
lid lacerations, 90 |
|
|
ocular medication, 696–7 |
295–6 |
ocular trauma, 80–1 |
|
|
intravitreal injection, 697 |
Tolosa—Hunt syndrome, |
orbital fractures |
|
|
subconjunctival injection, |
484 |
assessment, 87–8 |
|
|
696 |
Tonometer checks and |
treatment, 89 |
|
|
subtenon and peribulbar |
calibration, 18 |
penetrating trauma/IOFBs |
|
|
injections, 697 |
Topical anesthesia, 690 |
assessment, 95–6 |
|
|
topical, 696 |
Topical antibiotics, 698 |
treatment, 97–8 |
|
|
systemic corticosteroids |
Topical antihistamines, 701 |
tetanus status and |
|
|
contraindications, 706 |
Topical anti-inflammatory |
prophylaxis, 82–3 |
|
|
efficacy, 706 |
agents, 700–1 |
Traumatic optic neuropathy, |
|
|
indications and |
corticosteroids, 700–1 |
93 |
|
|
mechanism, 706 |
topical antihistamines, |
Treponema pallidum, 394–5 |
|
|
monitoring, 706–7 |
701 |
Trichiasis, 108 |
|
|
routes of administration, |
Topical glaucoma |
Trifluridine, 174–5 |
|
|
706 |
medications, 702–3 |
Trisomy syndromes, 638 |
|
|
side effects, 707, 708 |
β-blockers, 702 |
Tropheryma whippelii, 359 |
